Anavex Life Sciences Corp.
AVXL | NASDAQ
$2.46
+$0.06 (+2.50%)
Sep 22, 2026, 10:35 AM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 118.33M | 127.42M | 131.75M | 102.58M | 101.16M | 115.77M | 120.78M | 132.19M | 138.76M | 139.39M | 143.77M | 151.02M | 154.82M | 153.47M | 143.62M | 149.16M | 153.2M | 153.34M | 151.15M | 152.11M | 157.56M | 75.86M | 47.36M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 89K | 234K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -89K | n/a | n/a | 3.36M | n/a | n/a | n/a | 3.55B | n/a | n/a | n/a | 9.51M | n/a | n/a | n/a |
Receivables | 995K | 932K | 844K | 809K | 820K | 666K | 2.56M | 2.45M | 1.72M | 3.79M | 3.55M | 2.71M | 2.17M | 4.74M | 4.09M | 3.19M | 6.56M | 6.47M | 5.37M | 9.14M | 8.6M | 7.33M | 6.58M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 412K | 396K | 429K | -820K | 702K | 711K | 931K | 1.06M | 1.35M | 756K | 653K | 827.57K | 981.77K | 655.64K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 120.14M | 128.77M | 132.99M | 103.82M | 101.16M | 117.14M | 124.04M | 135.57M | 141.54M | 144.52M | 148.07M | 154.39M | 157.81M | 159.19M | 148.37M | 152.7M | 160.22M | 160.28M | 156.9M | 161.62M | 166.42M | 83.57M | 54.33M |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 234K | n/a | 3.36M | n/a | n/a | n/a | 3.55B | n/a | n/a | n/a | 9.51M | n/a | n/a | n/a |
Total Assets | 120.14M | 128.77M | 132.99M | 103.82M | 102.43M | 117.14M | 124.04M | 135.57M | 141.54M | 144.75M | 148.07M | 154.39M | 157.81M | 159.19M | 148.37M | 152.7M | 160.22M | 160.28M | 156.9M | 161.62M | 166.42M | 83.57M | 54.33M |
Account Payables | 3.66M | 2.52M | 2.64M | 4.25M | 6.74M | 7M | 4.57M | 9.63M | 3.5M | 3.73M | 4.29M | 4.32M | 4.15M | 6.28M | 5.29M | 3.82M | 3.13M | 2.63M | 4.63M | 4.74M | 4.18M | 3.66M | 4.22M |
Deferred Revenue | n/a | 805K | 805K | 805K | 805K | 829K | 829K | 842K | 917K | 917K | 917K | 917K | 916.76K | 916.76K | 916.76K | 444K | 443.83K | 443.83K | 443.83K | 443.83K | 443.83K | 487.11K | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 4.04M | 3.73M | 1.7M | 1.56M | 1.19M | 2.2M | 2.02M | 1.53M | 1.03M | n/a | n/a | n/a | 916.76K | 1.57M | 1.25M | 1.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 7.69M | 7.06M | 6.37M | 8.95M | 11.47M | 17.38M | 13.13M | 15.3M | 11.75M | 9.56M | 12.5M | 12.53M | 11.06M | 14.02M | 13.25M | 10.21M | 9.48M | 8.07M | 10.53M | 10.8M | 9.27M | 7.76M | 8.03M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Liabilities | 7.69M | 7.06M | 6.37M | 8.95M | 11.47M | 17.38M | 13.13M | 15.3M | 11.75M | 9.56M | 12.5M | 12.53M | 11.06M | 14.02M | 13.25M | 10.21M | 9.48M | 8.07M | 10.53M | 10.8M | 9.27M | 7.76M | 8.03M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Book Value | 112.45M | 121.71M | 126.62M | 94.87M | 90.96M | 99.76M | 110.92M | 120.26M | 129.78M | 135.19M | 135.58M | 141.85M | 146.75M | 145.17M | 135.12M | 142.49M | 150.74M | 152.21M | 146.37M | 150.82M | 157.15M | 75.81M | 46.3M |
Book Value Per Share | 1.23 | 1.31 | 1.42 | 1.10 | 1.07 | 1.17 | 1.31 | 1.43 | 1.54 | 1.64 | 1.65 | 1.78 | 1.81 | 1.85 | 1.73 | 1.85 | 1.95 | 2 | 1.93 | 1.98 | 2.23 | 1.11 | 0.72 |
Common Stock | 93K | 93K | 93K | 87K | 85K | 85K | 85K | 85K | 85K | 84K | 82K | 82K | 81.39K | 80.24K | 78.03K | 77.94K | 77.94K | 77.16K | 76.16K | 75.92K | 75.15K | 70.03K | 66.96K |
Retained Earnings | -385.64M | -393.47M | -388.13M | -382.45M | -372.62M | -359.38M | -348.18M | -336.07M | -324.45M | -312.24M | -301.69M | -293.07M | -282.92M | -271.64M | -258.54M | -245.56M | -231.27M | -218.91M | -208.47M | -197.59M | -185.87M | -175.69M | -167.53M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -89K | -234K | n/a | n/a | n/a | n/a | n/a | 0 | 0 | -403.7K | 0 | 0 | 0 | n/a | n/a |
Shareholders Equity | 112.45M | 121.71M | 126.62M | 94.87M | 90.96M | 99.76M | 110.92M | 120.26M | 129.78M | 135.19M | 135.58M | 141.85M | 146.75M | 145.17M | 135.12M | 142.49M | 150.74M | 152.21M | 146.37M | 150.82M | 157.15M | 75.81M | 46.3M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 89K | 234K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AVXL